Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-415
HR+
Luminal
Ixabepilone
TUBB
TUBB
7512.095
uM
0.00042
0.10389
-0.9926 -1.0000 0.1993 0.9414
0.6868
0.8452
MDA-MB-415
HR+
Luminal
Ixabepilone
TUBB
TUBB
7511.095
uM
1.3150
0.69985
0.3287 0.4157 2.8230 0.2318
0.8449
1.1565
MDA-MB-415
HR+
Luminal
JNK-IN-5A
JNK
JNK
10938.144
uM
inf
inf
0.4357 0.4357 0.0000 0.4162
0.0687
1.1369
MDA-MB-415
HR+
Luminal
JNK-IN-5A
JNK
JNK
12333.168
uM
0.38751
0.40503
-0.0482 -0.1237 4.9998 0.5489
0.9553
0.5815
MDA-MB-415
HR+
Luminal
L-779450
BRAF
MAPK
10938.149
uM
inf
inf
0.7318 0.7318 0.0000 0.2167
0.1498
1.0006
MDA-MB-415
HR+
Luminal
L-779450
BRAF
MAPK
12333.166
uM
12.91650
37.99290
0.0293 -1.0000 1.0183 0.1891
0.7508
0.6353
MDA-MB-415
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7510.098
uM
inf
inf
0.9619 0.9619 0.0000 0.0329
-0.0298
0.9528
MDA-MB-415
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7512.098
uM
inf
inf
0.9367 0.9367 0.0000 0.0880
0.1521
0.9499
MDA-MB-415
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7511.098
uM
inf
inf
0.9618 0.9618 0.0000 0.0309
0.2078
1.2032
MDA-MB-415
HR+
Luminal
LBH589
HDAC
HDAC
10938.154
uM
0.05087
0.07103
-0.9778 -0.9703 3.2310 1.0859
0.8640
1.0425
MDA-MB-415
HR+
Luminal
LBH589
HDAC
HDAC
12333.167
uM
0.01363
0.03470
-0.9941 -0.9889 1.1673 1.0780
0.9927
0.6809
MDA-MB-415
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10938.154
uM
0.33007
2.30970
-0.9714 -1.0000 0.5647 0.5834
0.7181
1.0425
MDA-MB-415
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12333.167
uM
0.28479
0.83232
-0.9958 -1.0000 1.0244 0.7097
0.9104
0.6809
MDA-MB-415
HR+
Luminal
Mebendazole
12959.174
uM
0.37016
5.03160
-0.2608 -0.8222 0.3727 0.5042
0.9457
0.5020
MDA-MB-415
HR+
Luminal
Mebendazole
13587.174
uM
0.32163
0.37879
-0.2050 -0.1694 1.7834 0.5079
0.9728
0.6955
MDA-MB-415
HR+
Luminal
Methotrexate
DHFR
Metabolism
7512.084
uM
inf
inf
1.0500 1.0500 0.0000 -0.0491
-524.0720
0.7511
MDA-MB-415
HR+
Luminal
Methotrexate
DHFR
Metabolism
7510.084
uM
inf
inf
0.8517 0.8517 0.0000 0.0588
0.1386
0.8702
MDA-MB-415
HR+
Luminal
Methotrexate
DHFR
Metabolism
7511.084
uM
inf
0.03357
0.4726 0.5052 5.0000 0.3425
0.9922
1.1467
MDA-MB-415
HR+
Luminal
MG-132
Proteasome
Proteasome
10938.145
uM
0.02276
0.20522
-0.7075 -0.8569 0.4540 0.8670
0.9728
1.1073
MDA-MB-415
HR+
Luminal
MG-132
Proteasome
Proteasome
10938.145
uM
0.02276
0.20522
-0.7075 -0.8569 0.4540 0.8670
0.9728
1.1073
MDA-MB-415
HR+
Luminal
MG-132
Proteasome
Proteasome
12333.17
uM
0.18041
0.35077
-0.9948 -1.0000 1.6523 0.8729
0.9841
0.6683
MDA-MB-415
HR+
Luminal
MG-132
Proteasome
Proteasome
12333.17
uM
0.18041
0.35077
-0.9948 -1.0000 1.6523 0.8729
0.9841
0.6683
MDA-MB-415
HR+
Luminal
MG-132
Proteasome
Proteasome
14272.189
uM
1.04350
1.35260
-0.9797 -0.8110 3.7152 0.5702
0.9908
0.5095
MDA-MB-415
HR+
Luminal
MG-132
Proteasome
Proteasome
14272.189
uM
1.04350
1.35260
-0.9797 -0.8110 3.7152 0.5702
0.9908
0.5095
MDA-MB-415
HR+
Luminal
MG-132
Proteasome
Proteasome
14643.189
uM
1.46630
2.07980
-0.9457 -0.9390 3.0242 0.5668
0.9947
0.8604